These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37494064)

  • 1. Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies.
    Horner RL
    Expert Opin Ther Targets; 2023; 27(7):609-626. PubMed ID: 37494064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits.
    Perger E; Bertoli S; Lombardi C
    Expert Rev Respir Med; 2023; 17(8):663-673. PubMed ID: 37646222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility: A Translational, Placebo-Controlled Trial.
    Osman AM; Mukherjee S; Altree TJ; Delbeck M; Gehring D; Hahn M; Lang T; Xing C; Muller T; Weimann G; Eckert DJ
    Chest; 2023 Apr; 163(4):953-965. PubMed ID: 36435266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
    Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
    J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pharyngeal collapsibility and genioglossus reflex responses to negative pressure during the respiratory cycle in obstructive sleep apnoea.
    Osman AM; Carberry JC; Gandevia SC; Butler JE; Eckert DJ
    J Physiol; 2020 Feb; 598(3):567-580. PubMed ID: 31782971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.
    Aishah A; Eckert DJ
    Curr Opin Pulm Med; 2019 Nov; 25(6):594-601. PubMed ID: 31503212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a pharmacological target for genioglossus reactivation throughout sleep.
    Grace KP; Hughes SW; Horner RL
    Sleep; 2014 Jan; 37(1):41-50. PubMed ID: 24470694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy.
    Horner RL; Grace KP; Wellman A
    Respirology; 2017 Jul; 22(5):861-873. PubMed ID: 28544082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy.
    Eckert DJ
    Sleep Med Rev; 2018 Feb; 37():45-59. PubMed ID: 28110857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of pediatric obstructive sleep apnea.
    Katz ES; D'Ambrosio CM
    Proc Am Thorac Soc; 2008 Feb; 5(2):253-62. PubMed ID: 18250219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea.
    White DP; Younes MK
    Compr Physiol; 2012 Oct; 2(4):2541-94. PubMed ID: 23720258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired pharyngeal reflex responses to negative pressure: a novel cause of sleep apnea in multiple sclerosis.
    Hensen HA; Carberry JC; Krishnan AV; Osman AM; Mosch AH; Toson B; Tay KL; Eckert DJ
    J Appl Physiol (1985); 2022 Mar; 132(3):815-823. PubMed ID: 35050793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypnotics on obstructive sleep apnea endotypes and severity: Novel insights into pathophysiology and treatment.
    Carter SG; Eckert DJ
    Sleep Med Rev; 2021 Aug; 58():101492. PubMed ID: 33965721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.
    Lim R; Carberry JC; Wellman A; Grunstein R; Eckert DJ
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30590857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea.
    Sands SA; Eckert DJ; Jordan AS; Edwards BA; Owens RL; Butler JP; Schwab RJ; Loring SH; Malhotra A; White DP; Wellman A
    Am J Respir Crit Care Med; 2014 Oct; 190(8):930-7. PubMed ID: 25191791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
    Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
    J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Eskandari D; Zou D; Grote L; Hoff E; Hedner J
    J Clin Sleep Med; 2018 Mar; 14(3):309-317. PubMed ID: 29510792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Body Position on Physiological Factors that Contribute to Obstructive Sleep Apnea.
    Joosten SA; Edwards BA; Wellman A; Turton A; Skuza EM; Berger PJ; Hamilton GS
    Sleep; 2015 Sep; 38(9):1469-78. PubMed ID: 25761982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in upper airway dilator muscle coactivation during sleep: comparison of patients with obstructive sleep apnea and healthy subjects.
    Oliven R; Cohen G; Dotan Y; Somri M; Schwartz AR; Oliven A
    J Appl Physiol (1985); 2018 Feb; 124(2):421-429. PubMed ID: 29191983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold.
    Eckert DJ; Malhotra A; Wellman A; White DP
    Sleep; 2014 Apr; 37(4):811-9. PubMed ID: 24899767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.